Medical knowledge
Dr. Dwi Kemaladewi On A Promising New Therapeutic Strategy For LAMA2-CMD
Dr. Dwi Kemaladewi is playing a a key role in developing a novel therapeutic approach that has opened new treatment…
The knowledge base
-
![]()
Medical knowledge
-
![]()
Medical knowledge
Prothelia: Developing A Protein Replacement Therapy For LAMA2-CMD
Steven Axon is the CEO of Prothelia, a biopharmaceutical company based in Massachusetts, USA, committed to developing a promising new…
-
![]()
Research updates
Prof. Bert Smeets On The Development Of Autologous Muscle Stem Cell Treatment
Professor Bert Smeets is involved in a number of investigations looking into a muscle stem cell treatment strategy to treat…
-
![]()
Medical knowledge
Join the Congenital Muscle Disease International Registry
The Congenital Muscle Disease International Registry (CMDIR) aims to advance neuromuscular research by collecting vital data and by growing advocacy…
-
![]()
Research updates
Ph.D. Karlijn Bouman: understanding the progression of LAMA2-CMD
Drs. Karlijn Bouman (PhD Candidate) is part of a team of Dutch doctors and researchers that are carrying out a…
-
![]()
Research updates
Dr. Carsten Bönnemann on LAMA2-CMD clinical trial readiness
Dr. Carsten Bönnemann and Dr. Reghan Foley are running a natural history study for infants aged 0-5 years of age.…
The driving forces behind Lama2.com
Bekijk alle partners
